Siga Technologies (SIGA) Current Deferred Tax Assets (2011 - 2015)
Siga Technologies' (SIGA) quarterly Current Deferred Tax Assets came in at $7.3 million in Q3 2015, up 6.48% quarter-over-quarter from $6.8 million in Q2 2015.
Analysis
Siga Technologies (SIGA) Current Deferred Tax Assets (2011 - 2015) Analysis & Trends
Siga Technologies (SIGA) has reported Current Deferred Tax Assets for 5 consecutive years, with $7.3 million the latest figure, recorded in Q3 2015.
- For the quarter ending Q3 2015, Current Deferred Tax Assets changed N/A year-over-year to $7.3 million; the trailing twelve-month figure through Sep 2015 stood at $7.3 million (changed N/A YoY), and the FY2014 full-year result was $5.7 million, down 45.53% from the prior year.
- Current Deferred Tax Assets climbed to $7.3 million in Q3 2015 per SIGA's latest filing, from $6.8 million in the prior quarter.
- Across five years, Current Deferred Tax Assets topped out at $35.0 million in Q2 2013 and bottomed at $726203.0 in Q2 2012.
- Historically, Current Deferred Tax Assets has averaged $12.0 million across 5 years, with a median of $7.3 million in 2015.
- The sharpest annual moves came in 2013 and 2014: Current Deferred Tax Assets jumped 4726.17% in 2013, then plunged 77.41% in 2014.
- Over 5 years, Current Deferred Tax Assets stood at $727772.0 in 2011, then jumped by 4505.2% to $33.5 million in 2012, then plunged by 69.02% to $10.4 million in 2013, then tumbled by 45.53% to $5.7 million in 2014, then gained by 28.39% to $7.3 million in 2015.
- According to Business Quant data, Current Deferred Tax Assets over the past three periods registered $7.3 million, $6.8 million, and $6.3 million for Q3 2015, Q2 2015, and Q1 2015 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn |
| 10 | Siga Technologies | 220.19 Mn | 65.22 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2015 | 7.26 Mn |
| Jun 30, 2015 | 6.82 Mn |
| Mar 31, 2015 | 6.25 Mn |
| Dec 31, 2014 | 5.66 Mn |
| Jun 30, 2014 | 11.76 Mn |
| Mar 31, 2014 | 7.60 Mn |
| Dec 31, 2013 | 10.38 Mn |
| Sep 30, 2013 | 19.42 Mn |
| Jun 30, 2013 | 35.05 Mn |
| Mar 31, 2013 | 33.66 Mn |
| Dec 31, 2012 | 33.52 Mn |
| Sep 30, 2012 | 740,439.00 |
| Jun 30, 2012 | 726,203.00 |
| Mar 31, 2012 | 731,807.00 |
| Dec 31, 2011 | 727,772.00 |